Advertisement

Topics

Woodcock's 'Bias' In Sarepta Case Made Jenkins Worry About Future Drug Reviews

18:45 EDT 31 Jul 2017 | SCRIP

In memo to then-Commissioner Califf during review of Sarepta's Exondys 51, Jenkins wrote that he was concerned about leaving OND...

      

Related Stories

 

Original Article: Woodcock's 'Bias' In Sarepta Case Made Jenkins Worry About Future Drug Reviews

NEXT ARTICLE

More From BioPortfolio on "Woodcock's 'Bias' In Sarepta Case Made Jenkins Worry About Future Drug Reviews"

Quick Search
Advertisement